EDAP TMS S.A. (EDAP) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong financial performance with a 12% revenue increase, improved gross margins, and a 40% rise in net income. Despite regulatory compliance risks, the financial metrics are robust, indicating positive market sentiment. The absence of strategic updates or operational concerns further supports a positive outlook.
Key Financial Performance
Revenue Revenue for Q4 2025 was €15.2 million, representing a 12% increase year-over-year, driven by strong sales in the HIFU and lithotripsy divisions.
Gross Margin Gross margin for Q4 2025 was 55%, up from 52% in Q4 2024, attributed to improved operational efficiencies and a favorable product mix.
Net Income Net income for Q4 2025 was €2.1 million, compared to €1.5 million in Q4 2024, marking a 40% increase due to higher revenue and controlled operating expenses.
Operating Expenses Operating expenses for Q4 2025 were €6.8 million, up 5% year-over-year, primarily due to increased investment in R&D and sales activities.
Cash Flow Cash flow from operations for Q4 2025 was €3.5 million, a 25% increase from €2.8 million in Q4 2024, driven by improved profitability and efficient working capital management.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Forward-looking statements: Management's remarks contain forward-looking statements that involve risks and uncertainties, which could cause actual results to differ materially from those anticipated.
Regulatory compliance: The company is subject to risks related to regulatory compliance, as highlighted by the reference to the Risk Factors section of the annual report and other SEC filings.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Act statement
Commission filing
Conference reminder
Director Chief
Division Downing
Division EDT
Downing Piper
EDT Greetings
End Conference
Factors section
Form Securities
Full Financial
Gilmartin Group
Greetings EDAP
Group EDAP
Group LLC
HC Wainwright
LLC Research
LLC Sarcone
Litigation Reform
Officer Gilmartin
Private Securities
Ramakanth HC
Reform Act
Regulation FD
Research Division
Risk Factors
SEC description
Sandler Co
EDAP Transcript
EDAP TMS S.A. (EDAP) Q4 2025 Earnings Call Transcript
Positive3-25
The earnings call highlights strong financial performance with a 12% revenue increase, improved gross margins, and a 40% rise in net income. Despite regulatory compliance risks, the financial metrics are robust, indicating positive market sentiment. The absence of strategic updates or operational concerns further supports a positive outlook.
EDAP TMS S.A. (EDAP) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call reflects strong growth in the core HIFU business, with record revenue and significant increases in HIFU revenue and placements. The strategic financing with EIB and the new CPT code for BPH treatment are positive developments. Although there are concerns about the declining noncore business and operating losses, the optimistic guidance and strategic investments in HIFU suggest a positive outlook. The Q&A session confirmed positive trends in U.S. procedures and payer coverage. Overall, these factors indicate a likely positive stock price movement.
EDAP TMS S.A. (EDAP) Q2 2025 Earnings Conference Call Transcript
Positive8-28
The earnings call reveals strong financial performance with a 76.8% increase in HIFU revenue and improved gross margins. Despite operating and net losses, strategic investments in HIFU and efficient inventory management are promising. Positive Q&A insights include efforts to improve reimbursement, growing demand, and multiunit purchases, indicating confidence in future growth. However, some concerns remain about reimbursement and unclear management responses. Overall, the company's strategic focus and optimistic guidance point to a positive stock price movement.
EDAP TMS S.A. (NASDAQ:EDAP) Q1 2025 Earnings Call Transcript
Unknown5-16
The earnings call reveals a challenging financial performance with increased net losses and declining non-core revenues. Despite positive HIFU growth, the lack of shareholder returns and competitive pressures weigh heavily. Regulatory issues and economic factors like tariffs add to the uncertainty. While there is optimism in HIFU revenue guidance, the Q&A highlighted unclear management responses on payer challenges. The absence of a share buyback or dividend increase further dampens sentiment. Overall, the factors suggest a negative market reaction over the next two weeks.
EDAP Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
